Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FEMY
#3687
Femasys Inc. Common Stock
0.5
7
0.00%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-3.39%
6 month change
+50.00%
Year Change
-65.45%
Previous Close
0.5
7
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volume
5
Markets
US Stock Market
Healthcare
FEMY
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Femasys receives CPT code approval for infertility treatment
Femasys expands European presence with Swiss distribution deal
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
PharmaCyte Biotech stock soars after successful Femasys stake sale
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential
FDA approves Femasys to continue pivotal trial for non-surgical birth control
Femasys begins post-market study for non-surgical birth control in EU